Overview

Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd

Status:
Recruiting
Trial end date:
2022-01-15
Target enrollment:
Participant gender:
Summary
To Evaluate the Outcome of cardio selective beta1 (β1-) blockers use in patients with chronic obstructive pulmonary disease. Patient education about the COPD and their medications.
Phase:
Phase 4
Details
Lead Sponsor:
Ain Shams University
Treatments:
Nebivolol